Asia Pacific Compound Management Market

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027

Analysis and Forecasts by Product & Services (Compound/Sample Management Products and Services); Sample Type (Chemical Compounds and Biosamples); Application (Drug Discovery, Gene Synthesis, Biobanking); End User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations (CROs), and Others) and Country.


No. of Pages: 156    |    Report Code: TIPRE00006670    |    Category: Technology, Media and Telecommunications

Available Report Formats

pdf-format excel-format pptx-format
Buy Now
Asia Pacific Compound Management Market

The Asia Pacific compound management market is expected to reach US$ 167.94 Mn in 2027 from US$ 50.78 Mn in 2018. The market is estimated to grow with a CAGR of 14.9 % from 2019-2027.

 

The growth of the compound management market is driven by factors such as, rising drug discovery activity in the Asian countries and initiatives undertaken by the government bodies. However, market growth is likely to slow down due to shortage of skilled professionals in the region.

 

Asian countries, such as Korea, Japan, China, and Malaysia, among others, have been actively functioning in the biobanking sector. Biobanks in Korea operate in collaboration and are coordinated collectively by six government ministries. Human biobanks in Korea are administered by the Ministry of Food and Drug Safety; the Ministry of Science, ICT and Future Planning, and The Ministry of Health and Welfare. As per stats by Thermo Fisher, during 2016 Korea had more than 60 biobanks. In Japan, biobanks are managed by small laboratories that are present in academic or governmental institutes. However, recently, the Japanese government reorganized funding and management of biobanks to ensure quality management of biological resources. Moreover, the government is also strengthening its life science research by establishing a dedicated funding agency which provides strategic support for biobanks handling useful resources for industrialization.

 

Among the countries in the region, China is expected to lead the market during the forecast period. The growth of the market is primarily attributed to the established pharmaceutical market, increasing R&D expenditures by the pharmaceutical and biopharmaceutical companies, an increasing number of clinical trials due to lower cost, and favorable regulatory policies. China has the world’s second-largest pharmaceutical market. The excessive population in China, coupled with the rise of various communicable and non-communicable diseases, are majorly driving the growth of the pharmaceutical companies in China and making it a prime market in the Asia Pacific region.

 

China Compound Management Market Revenue and Forecasts to 2027 (US$ Mn)

 

Get more information on this report

Asia Pacific Compound Management Strategic Insights

Strategic insights for the Asia Pacific Compound Management provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/asia-pacific-compound-management-market-strategic-framework.webp
Get more information on this report

Asia Pacific Compound Management Report Scope

Report Attribute Details
Market size in 2018 US$ 50.78 Million
Market Size by 2027 US$ 167.94 Million
Global CAGR (2019 - 2027) 14.9 %
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Product & Services
  • Compound/Sample Management Products and Services
By Sample Type
  • Chemical Compounds and Biosamples
By Application
  • Drug Discovery
  • Gene Synthesis
  • Biobanking
By End User
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Contract Research Organizations
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Biosero Inc.
  • Meridian Bioscience
  • Evotec
  • Icagen, Inc.
  • TCG Lifesciences Pvt. Ltd.
  • TTP Labtech
  • Frontier Scientific Services
  • Hamilton Company
  • Tecan Trading AG
  • Brooks Life Sciences
  • Get more information on this report

    Asia Pacific Compound Management Regional Insights

    The geographic scope of the Asia Pacific Compound Management refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/asia-pacific-compound-management-market-geography.webp
    Get more information on this report

     

    ASIA PACIFIC COMPOUND MANAGEMENT – MARKET SEGMENTATION

    By Product & Services

    • Compound/Sample Management Products
      • Instruments
        • Automated Compound/Sample Storage Systems
        • Manual Compound/Sample Storage Systems
        • Automated Liquid Handling Systems
      • Software
    • Services

     

    By Sample Type

    • Chemical Compounds
    • Biosamples

     

    By Application

    • Drug Discovery
    • Gene Synthesis
    • Biobanking

     

    By End User

    • Pharmaceutical Companies
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Others

     

    Company Profiles

    • Biosero Inc.
    • Meridian Bioscience
    • Evotec
    • Icagen, Inc.
    • TCG Lifesciences Pvt. Ltd.
    • TTP Labtech
    • Frontier Scientific Services
    • Hamilton Company
    • Tecan Trading AG
    • Brooks Life Sciences

    The List of Companies - Asia Pacific Compound Management Market

    The List of Companies - Asia Pacific Compound Management Market

    1. Biosero Inc.
    2. Meridian Bioscience
    3. Evotec
    4. Icagen, Inc.
    5. TCG Lifesciences Pvt. Ltd.
    6. TTP Labtech
    7. Frontier Scientific Services
    8. Hamilton Company
    9. Tecan Trading AG
    10. Brooks Life Sciences

     

    Frequently Asked Questions
    How big is the Asia Pacific Compound Management Market?

    The Asia Pacific Compound Management Market is valued at US$ 50.78 Million in 2018, it is projected to reach US$ 167.94 Million by 2027.

    What is the CAGR for Asia Pacific Compound Management Market by (2019 - 2027)?

    As per our report Asia Pacific Compound Management Market, the market size is valued at US$ 50.78 Million in 2018, projecting it to reach US$ 167.94 Million by 2027. This translates to a CAGR of approximately 14.9 % during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Compound Management Market report typically cover these key segments-

    • Product & Services (Compound/Sample Management Products and Services)
    • Sample Type (Chemical Compounds and Biosamples)
    • Application (Drug Discovery, Gene Synthesis, Biobanking)
    • End User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations)

    What is the historic period, base year, and forecast period taken for Asia Pacific Compound Management Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Compound Management Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in Asia Pacific Compound Management Market?

    The Asia Pacific Compound Management Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Biosero Inc.
  • Meridian Bioscience
  • Evotec
  • Icagen, Inc.
  • TCG Lifesciences Pvt. Ltd.
  • TTP Labtech
  • Frontier Scientific Services
  • Hamilton Company
  • Tecan Trading AG
  • Brooks Life Sciences
  • Who should buy this report?

    The Asia Pacific Compound Management Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Compound Management Market value chain can benefit from the information contained in a comprehensive market report.